Keyphrases
Herpes Simplex Virus Type 1 (HSV-1)
100%
Rectal Carcinoma
100%
Virus Delivery
100%
Herpes Simplex Virus
100%
Antitumor Effect
100%
Oncolytic Activity
33%
Novel Therapeutics
16%
Therapeutic Challenges
16%
Tumor
16%
Improved Survival
16%
Viral Replication
16%
Survival Rate
16%
Colorectal Cancer
16%
Antiviral Activity
16%
Solid Tumors
16%
Adjacent Organ
16%
Inhibitor-2
16%
2-Aminopurine
16%
Two-vector
16%
Rectum
16%
Intratumoral Injection
16%
Systemic Toxicity
16%
Sphincter Function
16%
Surgical Resection
16%
Anal Sphincter
16%
Radiotherapy
16%
Local Delivery
16%
Oncolytic Effect
16%
Double-stranded RNA-dependent Protein Kinase
16%
Tumor Survival
16%
Chemical Inhibitors
16%
Therapeutic Modalities
16%
Protein Kinase PKR
16%
Human Colon Cancer
16%
Rectal Tumor
16%
PKR Inhibitor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Human Alphaherpesvirus 1
100%
Herpes Simplex Virus
100%
Rectum Carcinoma
100%
Neoplasm
33%
Mouse
33%
Protein Kinase R
33%
Side Effect
16%
Infection
16%
Malignant Neoplasm
16%
Colon Cancer
16%
Solid Malignant Neoplasm
16%
2 Aminopurine
16%
Rectum Tumor
16%
Antiviral Activity
16%
Rectum Cancer
16%
Survival Rate
16%